RCS - Alpha Growth PLC - Addition to Investment Team and Launch of New Fund
05/01/2026 08:15
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260105:nRSE5509Na&default-theme=true
RNS Number : 5509N Alpha Growth PLC 05 January 2026
REACH: non-regulatory announcement
Alpha Growth plc
("Alpha" or the "Company")
Alpha Longevity Management Ltd Expands Global Platform with Launch of Alpha
Alternative Global Fund and Strengthening of Executive Leadership Team
Alpha Growth plc, (www.algwplc.com (http://www.algwplc.com) ) a leading global
financial services specialist in the multi-billion dollar market of longevity
assets and insurance linked asset and wealth management is pleased to announce
that one of its group companies, Alpha Longevity Management Ltd, an asset
management subsidiary of Alpha Growth plc, today announced two significant
developments marking the firm's continued global expansion: the launch of the
Alpha Omni Funds ICAV, authorized by the Central Bank of Ireland including the
Alpha Alternative Global Fund, a new flagship strategy, and the appointment of
Andre Severino as Senior Managing Director and Chief Investment Officer and
Charlie Devin Smith as Managing Director and Senior Portfolio Manager.
The Alpha Alternative Global Funds an evergreen investment vehicle designed to
provide institutional and qualified investors with access to diversified
portfolios of alternative and esoteric assets. The fund will target long-term
capital appreciation through exposure to private market credit and specialized
sectors including litigation-linked financing, structured settlements and
royalties, complemented by liquid public securities to manage liquidity.
"This launch marks a pivotal step in the evolution of Alpha Longevity
Management as a global platform for differentiated and uncorrelated investment
strategies," said Gobind Sahney, Executive Chairman of Alpha Growth plc. "The
Alpha Alternative Global Fund reflects our ability to identify and structure
institutional-grade opportunities across private markets, offering investors
unique access to uncorrelated assets, while the addition of Andre and Charlie
further enhances our investment depth and leadership capabilities as we scale
internationally."
Mr. Severino, with over 25 years of international investment experience across
fixed income, currencies, and derivatives, will lead Alpha Longevity
Management's global investment strategy, expanding on the firm's existing
insurance-linked and longevity-based solutions for institutional investors.
Prior to joining Alpha, he served as Head of Global Fixed Income for Nikko
Asset Management's London based global FI team, responsible for the company's
flagship global bond strategy, and for the dramatic growth in its Japanese
institutional business, launching a diverse range of progressive solutions
funds to meet institutional client needs.
Mr. Devin Smith, joining as Senior Portfolio Manager, brings extensive
experience in global fixed income and derivatives trading. Formerly a Senior
Trader at Nikko Asset Management, he managed a $5 billion global bond fund and
contributed to a $16 billion platform with a focus on liquidity and
quantitative strategies.
Operating across the U.S., Bermuda, and EMEA, Alpha Longevity Management
manages and develops investment strategies centered on longevity and esoteric
assets that bridge traditional life insurance solutions with sophisticated
alternative structures. The Alpha Omni Funds ICAV, domiciled in Ireland,
serves as the firm's regulated fund platform, offering institutional investors
access to diversified portfolios of life settlements, annuities, and
alternative yield opportunities.
"The Alpha Alternative Global Fund underscores our commitment to delivering
institutional investors an entry point into niche private market assets
blended with public market instruments to deliver optimal risk adjusted
returns," said Andre Severino, Chief Investment Officer. "Our approach
combines actuarial precision with deep experience in global fixed income and
structured products to deliver differentiated sources of return."
Alpha Longevity Management Ltd - Andre Severino as@algwplc.com (mailto:as@algwplc.com)
Charlie Devin-Smith cds@algwplc.com (mailto:cds@algwplc.com)
UK Investor Relations - Mark Treharne ir@algwplc.com (mailto:ir@algwplc.com)
About Alpha Longevity Management Ltd
Alpha Longevity Management Ltd, a subsidiary of Alpha Growth plc, is a
Bermuda-based asset manager focused on longevity and esoteric asset
strategies. Through its regulated fund structures in Bermuda and Ireland, the
firm provides institutional and high-net-worth investors with access to
uncorrelated, long-term investment opportunities across insurance-linked,
private credit, and alternative yield markets.
About Alpha Growth plc
Specialist in Life Insurance, Esoteric and Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist
consultancy, advisory, and supplementary services to institutional and
qualified investors globally in the multi-billion dollar market of longevity
assets and insurance linked asset and wealth management. Building on its
well-established network, the Alpha Growth group has a unique position in the
insurance and asset services and investment business with global reach.
Disclaimer
This news release relates to the Alpha Omni Funds ICAV and its sub-fund Alpha
Alternative Global Fund. The ICAV is an alternative investment fund domiciled
in Ireland and authorised by the Central Bank of Ireland as a qualifying
investor alternative investment fund. The ICAV is managed in accordance with
the Alternative Investment Fund Managers Directive. Investment management
services are provided by Alpha Longevity Management Ltd, licensed by the
Bermuda Monetary Authority and authorised by the Central Bank of Ireland to
act as a non-EU Investment Manager to Irish authorised investment funds.
This communication is provided for information purposes only and does not
constitute an offer, recommendation or invitation to subscribe for, or a
solicitation to purchase, any interests in the Fund. Any such offer or
solicitation may be made only in accordance with applicable laws and
regulations and on the basis of the Fund's offering documents.
This communication is directed solely at professional investors and qualifying
investors and is not intended for distribution to retail investors. This
communication is not intended for distribution to, or use by, any person or
entity in any jurisdiction where such distribution would be contrary to
applicable law or regulation.
***END***
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAGGGDBUSGDGLS
Copyright 2019 Regulatory News Service, all rights reserved